GNS Announces Oral Poster Presentation and Abstract at ASH
The 64th ASH Annual Meeting and Exposition is scheduled to take place December 10-13, 2022 in New Orleans, Louisiana. GNS today announced an oral poster presentation and an abstract highlighting insight from the Gemini Digital Twin model in Multiple Myeloma. Oral and Poster Abstracts: Monday, December 12, 2022: 6:00 PM-8:00 PM Abstract Number 4804: Causal AI in silico Patient […]
GNS Announces Oral Poster Presentation and Abstract at CTAD
The 15th annual Clinical Trials on Alzheimer’s Disease (CTAD) will be held in San Francisco on November 29 – December 2, 2022. GNS today announced an oral poster presentation and an abstract highlighting insight from the Gemini Digital Twin model in Alzheimer Disease. Oral Poster Presentation: Friday, December 2nd from 8am to 5pm PT. Abstract […]
Intelligent Technology Brings Companies To A New Moment Of Truth
“Algorithms have long been used to uncover correlations but now they are closing in on more human-like abilities such as common sense and the understanding of causation.” Paul R. Daugherty and H. James Wilson, discuss in this article the future of AI and refer to it as A New Moment of Truth. GNS causal AI […]
GNS Attending BioTechX Europe’s Largest Congress
BioTechX is Europe’s largest congress covering latest breakthroughs in pharmaceutical development and healthcare. This year, GNS is attending this world-class congress, and our own Colin Hill will be speaking on Nov 8 at 14:50 (CET) on the Recent Application of Digital Twins in Drug Discovery and Development for Alzheimer’s Disease. Make sure to bookmark your […]
Bruce Church to Speak at the Human Vaccines Project
Over 20 years ago, the sequencing of the human genome revolutionized biomedical research and ushered in a new era of precision medicine. On September 27-29, 2022, The Human Vaccines Project will convene a summit to map out the next frontier in human biology: How to Build an AI Model of the Human Immunome. The primary […]
Colin Hill to Give Keynote at the 26th Annual Merck Technology Symposium
The Merck Technology Symposium is an annual event that brings together upwards of 2,000 scientists and over 70 external vendors to hear about innovations in new therapeutic approaches, applications of new technology, and accelerating the pace at which we deliver medicines to patients. The meeting will be organized around several tracks illustrating the various ways […]
Colin Hill moderating Fireside Chat at Longwood Healthcare Leaders Fall meeting
Once again, GNS is a proud supporter of Longwood Healthcare Leaders. This Fall webconference brings together leading biopharma CEOs, heads of R&D, top academic researchers, and healthcare investors for an off-the-record forum focused on accelerating the translation of discoveries into medicines to help patients. On Thursday, September 22, 2022, our CEO Colin Hill will be […]
Panel discussion “The State of AI in Biotech” at the State of Biotech by GEN EDGE
Join the editors of Genetic Engineering & Biotechnology News and an all-star line-up of speakers as we analyze the state of biotechnology – a celebration of innovation, emerging technologies, and clinical successes and an in-depth appraisal of the headwinds and challenges facing the industry. On Wednesday, September 21th, 2022, our CEO Colin Hill, will be on […]
Meet us at the 19th International Myeloma Society Annual Meeting
This year we are attending the 19th International Myeloma Society Annual Meeting in Los Angeles. Come meet Team GNS and our data partner Multiple Myeloma Research Foundation (MMRF) to explore how we are working together to accelerate Multiple Myeloma drug discovery and development with Al Digital Twins. Please fill out the form below and a member of our […]
Meet us at AI Drug Driven Discovery Summit
Join us at the AI Drug Driven Discovery Summit, August 16-17, 2022 in Boston. Don’t hesitate to let us know if you’d like to schedule a meeting beforehand and discuss drug discovery partnership opportunities.